Postdoctoral Research Scientist
The institute’s internationally recognised Signalling programme often works in collaboration with the Biotech or Pharma sector to translate our research. This position is a collaboration between the Cook laboratory at the Babraham Institute, PhoreMost (an SME based on the Babraham Research Campus) and Plexxikon (based in California).
The successful candidate will work on a project directed towards developing novel cell-based phenotypic screening protocols to find inhibitors of growth factor signalling pathways that are frequently deregulated in cancer.
The ideal candidate must have a PhD in Biochemistry, Cell Biology or Molecular Biology with a track record of producing excellent published work. Experience of assaying growth factor signalling transduction, cell proliferation and apoptosis, confocal immunofluorescence microscopy and high content imaging are essential. In addition, experience in rigorously controlled RNAi is required. Knowledge of cancer cell biology and experience in gene reporter assays will be advantageous.
Funding for this position is available for 18 months in the first instance.
Full details of the position can be found here.
On applying please quote reference PH-SC-LTC.
Closing date for completed applications is Friday, 15 June 2018.
NO AGENCIES PLEASE
The Babraham Institute holds a silver Athena SWAN award and is committed to promoting and developing a culture of excellence, diversity and mutual respect that supports the Institute’s ambitions and attracts highly motivated and talented people.
The Babraham Institute is a user of the disability symbol and is positive about disabled people.
The Babraham Institute receives strategic funding from the Biotechnology and Biological Sciences Research Council and is an Equal Opportunities Employer.
Please complete the following before submitting your application:
Please submit your Covering Letter
Please submit your CV
Please submit your completed Application Form
Please submit your Equal Opportunities Form
Job Description, Person Specification & Benefits Summary